Tag: Oxygen Concentrator
O2 Concepts: ‘We want to grow in 2025’
March 14, 2025Liz Beaulieu, Editor
MIDDLEBURY, Conn. – Paul Miller sees much of his new role at O2 Concepts as bringing organization and support to a company with both a strong sales team and product portfolio.
Miller, who previously worked at Medline for nearly 20 years, was announced as the new executive vice president of sales for O2 Concepts in December.
“It’s a strong sales team with a lot of respiratory expertise,” he said. “They’re former F&P, Respironics and ResMed salespeople...
Inogen returns to growth
February 26, 2025HME News Staff
GOLETA, Calif. - Inogen reported total revenue of $80.1 million for the fourth quarter of 2024, a 5.5% increase compared to the same period in 2023, and $335.7 million for the full year 2024, a 6.4% increase compared to 2023.
The company’s performance was primarily driven by higher demand and new customers in international and domestic business-to-business sales, partially offset by lower direct-to-consumer sales and lower rental revenue as a result of its initiatives to enhance overall...
Urgent recall issued for TrueAire-5 oxygen concentrator
February 6, 2025HME News Staff
WASHINGTON – The U.S. Food and Drug Administration has issued an urgent recall for the JMCC5A Ni/TruAire-5 Oxygen Concentrator due to the device spontaneously catching fire. The FDA says all units from a specified serial number range must be immediately discontinued from use and removed from service and promptly returned to Compass Health Brands. The affected devices are Model O2C5L with serial number range JA2311000001-JA2312000740. On Nov. 26, 2024, Jiangsu Jumao X-Care Medical Equipment...
FDA issues draft guidance on pulse oximeters
January 9, 2025HME News Staff
WASHINGTON – The U.S. Food and Drug Administration on Jan. 6 issued new draft guidance to help improve the accuracy and performance of pulse oximeters that are used for medical purposes across populations with a range of skin pigmentations. The FDA is requesting comments on “Pulse Oximeters for Medical Purposes – Non-Clinical and Clinical Performance Testing, Labeling and Premarket Submission Recommendations” for 60 days, until March 10. The draft guidance includes information...
O2 Concepts taps Paul Miller for sales role
December 16, 2024HME News Staff
MIDDLEBURY, Conn. - O2 Concepts has appointed Paul Miller, formerly of Medline, as its new executive vice president of sales. Miller has more than 20 years of experience driving sales growth and leading high-performing teams, most recently at Medline, where he spearheaded the company’s re-emergence in the HME industry, the company says. “Paul’s track record of exceptional leadership and results makes him the ideal fit to lead our team as we broaden our market presence,” said...
Drive launches PulmO2 for disadvantaged regions
October 14, 2024HME News Staff
PORT WASHINGTON, N.Y. – Drive DeVilbiss Healthcare has launched the PulmO2 Oxygen Concentrator to improve access to oxygen therapy in low- and middle-income countries. To ensure effective delivery and operation, DDH collaborated with Sanrai International, a key partner experienced in bringing medical equipment to underserved areas, to tap into the intricacies of underserved regions and ensure the concentrator's effectiveness in the most challenging settings. "Our mission has always...
Philips exit: ‘Nothing fazes us anymore'
February 16, 2024Theresa Flaherty, Managing Editor
YARMOUTH, Maine – A decision by Philips to exit a large chunk of the U.S. respiratory market will have a significant impact on the market, say 70% of respondents to a recent HME Newspoll.
Philips announced in January that it was discontinuing sales for 19 sleep and respiratory products, including oxygen concentrators and ventilators.
“There are very few big manufacturers left,” wrote one respondent. “Respironics had many high-quality products that will be...
Manufacturers seek to ‘take pain away’
February 2, 2024Liz Beaulieu, Editor
YARMOUTH, Maine – The decision by Philips to discontinue its line of oxygen concentrators in the U.S. will leave a significant gap in the market, but manufacturers say they’re ramping up to meet increased demand, with lessons learned from the COVID-19 pandemic and the CPAP recall.
Just prior to announcing it had agreed on the terms of a consent decree related to the recall, Philips announced on Jan. 25 that it was discontinuing sales for 19 products, including the EverFlo home...
Belluscura announces increased offer
January 22, 2024HME News Staff
LONDON and PLANO, Texas – The boards of Belluscura and TMT Acquisition have announced the terms of a recommended share offer to be made by Belluscura for the whole of the issued and to be issued share capital of TMT Acquisition. Having regard to the Belluscura share price in recent weeks, the companies have agreed on an increase in the number of new Belluscura shares to be offered in exchange for TMT acquisition shares. The value of a TMT acquisition share under the offer, based on the closing...
Belluscura increases visibility
April 21, 2023Liz Beaulieu, Editor
LONDON and PLANO, Texas – Belluscura has secured a marketing agreement with the popular website GoodRx to increase direct-to-consumer sales of its X-PLOR portable oxygen concentrator.
Santa Monica, Calif.-based GoodRx operates www.goodrx.com and a mobile app that allow users to compare drug prices and get free coupons that they can use at the pharmacy. The company, which also operates a telehealth platform, estimates it has helped Americans save $35 billion on health care and prescription...